These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23414839)

  • 21. Structural and chemical basis for enhanced affinity and potency for a large series of estrogen receptor ligands: 2D and 3D QSAR studies.
    Salum Lde B; Polikarpov I; Andricopulo AD
    J Mol Graph Model; 2007 Sep; 26(2):434-42. PubMed ID: 17349808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification, pharmacological evaluation and binding mode analysis of novel chromene and chromane based σ1 receptor ligands.
    Laurini E; Harel D; Marson D; Schepmann D; Schmidt TJ; Pricl S; Wünsch B
    Eur J Med Chem; 2014 Aug; 83():526-33. PubMed ID: 24996139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3D-QSAR and docking studies on transforming growth factor (TGF)-beta receptor 1 antagonists.
    Geldenhuys WJ; Nakamura H
    Bioorg Med Chem Lett; 2010 Mar; 20(6):1918-23. PubMed ID: 20176484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of CoMFA and CoMSIA 3D-QSAR and docking studies in optimization of mercaptobenzenesulfonamides as HIV-1 integrase inhibitors.
    Kuo CL; Assefa H; Kamath S; Brzozowski Z; Slawinski J; Saczewski F; Buolamwini JK; Neamati N
    J Med Chem; 2004 Jan; 47(2):385-99. PubMed ID: 14711310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding site exploration of CCR5 using in silico methodologies: a 3D-QSAR approach.
    Gadhe CG; Kothandan G; Cho SJ
    Arch Pharm Res; 2013 Jan; 36(1):6-31. PubMed ID: 23325486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3D-QSAR studies of triazafluorenone inhibitors of metabotropic glutamate receptor subtype 1.
    Nataraja Sekhar Y; Ravikumar M; Ravi Shashi Nayana M; Mallena SC; Kishore Kumar M
    Eur J Med Chem; 2008 May; 43(5):1025-34. PubMed ID: 17822809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphing of Ibogaine: A Successful Attempt into the Search for Sigma-2 Receptor Ligands.
    Floresta G; Dichiara M; Gentile D; Prezzavento O; Marrazzo A; Rescifina A; Amata E
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The sigma enigma: in vitro/in silico site-directed mutagenesis studies unveil σ1 receptor ligand binding.
    Brune S; Schepmann D; Klempnauer KH; Marson D; Dal Col V; Laurini E; Fermeglia M; Wünsch B; Pricl S
    Biochemistry; 2014 May; 53(18):2993-3003. PubMed ID: 24766040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA.
    Akula N; Lecanu L; Greeson J; Papadopoulos V
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6277-80. PubMed ID: 17049234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computational insights into the inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid analogs: three-dimensional quantitative structure-activity relationship and molecular docking studies.
    Yang N; Wang J; Wang ZW; Wang QH; Yang HG; Wang XJ; Cheng MS
    Chem Biol Drug Des; 2012 Jun; 79(6):1063-71. PubMed ID: 22405057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. QSAR studies on aminothiazole derivatives as aurora a kinase inhibitors.
    Qin J; Xi L; Du J; Liu H; Yao X
    Chem Biol Drug Des; 2010 Dec; 76(6):527-37. PubMed ID: 21040493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3D-chiral quadratic indices of the 'molecular pseudograph's atom adjacency matrix' and their application to central chirality codification: classification of ACE inhibitors and prediction of sigma-receptor antagonist activities.
    Ponce YM; Diaz HG; Zaldivar VR; Torrens F; Castro EA
    Bioorg Med Chem; 2004 Oct; 12(20):5331-42. PubMed ID: 15388160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling ligand-receptor interaction for some MHC class II HLA-DR4 peptide mimetic inhibitors using several molecular docking and 3D QSAR techniques.
    Wei HY; Tsai KC; Lin TH
    J Chem Inf Model; 2005; 45(5):1343-51. PubMed ID: 16180911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3D-QSAR studies of farnesyltransferase inhibitors: a comparative molecular field analysis approach.
    Puntambekar D; Giridhar R; Yadav MR
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1821-7. PubMed ID: 16455255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
    J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3D-QSAR studies for the binding affinity toward (R, S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic acid receptor.
    Sharma RN; Thakar H; Vasu KK; Chaturvedi SC
    Acta Pharm; 2008 Sep; 58(3):335-45. PubMed ID: 19103570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative molecular field analysis (CoMFA) study using semiempirical, density functional, ab initio methods and pharmacophore derivation using DISCOtech on sigma 1 ligands.
    Jung D; Floyd J; Gund TM
    J Comput Chem; 2004 Aug; 25(11):1385-99. PubMed ID: 15185333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3D-QSAR and molecular docking studies on benzothiazole derivatives as Candida albicans N-myristoyltransferase inhibitors.
    Sheng C; Zhu J; Zhang W; Zhang M; Ji H; Song Y; Xu H; Yao J; Miao Z; Zhou Y; Zhu J; Lü J
    Eur J Med Chem; 2007 Apr; 42(4):477-86. PubMed ID: 17349719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations.
    Durdagi S; Mavromoustakos T; Chronakis N; Papadopoulos MG
    Bioorg Med Chem; 2008 Dec; 16(23):9957-74. PubMed ID: 18996019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of novel FLT-3 inhibitors based on dual-layer 3D-QSAR model and fragment-based compounds in silico.
    Shih KC; Lin CY; Chi HC; Hwang CS; Chen TS; Tang CY; Hsiao NW
    J Chem Inf Model; 2012 Jan; 52(1):146-55. PubMed ID: 22142286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.